Enhanced bioavailability of piroxicam via salt formation with ethanolamines

International Journal of Pharmaceutics

Volumn 297, Issue 1-2, 2005, Pages 156-161

  Gwak, Hye Sun ^a   Choi, Jun Shik ^b   Choi, Hoo Kyun ^b  

^a Ewha Womans University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Bioavailability; Dissolution; Ethanolamine; Piroxicam; Salt

Indexed keywords

ETHANOLAMINE DERIVATIVE; PIROXICAM; PIROXICAM DIETHANOLAMINE; PIROXICAM MONOETHANOLAMINE; PIROXICAM TRIETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG PENETRATION; DRUG SOLUBILITY; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHANOLAMINES; HYDROGEN-ION CONCENTRATION; MALE; PIROXICAM; RATS; RATS, WISTAR; SOLUBILITY;

EID: 19344378772     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.03.016     Document Type: Article

References (10)

1. S.G. Boundinot, E.D. Funderburg, and F.D. Boundinot Effects of age on the pharmacokinetics of piroxicam in rats J. Pharm. Sci. 82 1993 254 257
2. H.-A. Cheong, and H.-K. Choi Enhanced percutaneous absorption of piroxicam via salt formation with ethanolamines Pharm. Res. 19 2002 1372 1377
3. M. Fernández, M.V. Margarit, I.C. Rodríguez, and A. Cerezo Dissolution kinetics of piroxicam in solid dispersions with polyethylene glycol 4000 Int. J. Pharm. 98 1993 29 35
4. H.L. Heeb, R. Chun, D.E. Koch, M.A. Goatley, and R.P. Hunter Single dose pharmacokinetics of piroxicam in cats J. Vet. Pharmacol. Ther. 26 2003 259 263
5. J. Jinno, D.-M. Oh, J.R. Crison, and G.L. Amidon Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant J. Pharm. Sci. 89 2000 268 274
6. E. Kimura, C.A. Bersani-Amado, L.S. Sudo, S.R.J. Santos, and S. Oga Pharmacokinetic profile of piroxicam β-cyclodextrin, in rat plasma and lymph Gen. Pharmacol. 28 1997 695 698
7. E. Lipka, and G.L. Amidon Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems J. Control. Rel. 62 1999 41 49
8. L.K. Roskos, and F.D. Boudinot Effects of dose and sex on the pharmacokinetics of piroxicam in the rat Biopharm. Drug Dispos. 11 1990 215 225
9. C.A. Tagliati, E. Kimura, M.S. Nothenberg, S. Santos, and S. Oga Pharmacokinetic profile and gastric effect of zinc-piroxicam in rats Gen. Pharmacol. 33 1999 67 71
10. N. Yüksel, A. Karata, Y. Özkan, A. Savaser, S.A. Özkan, and T. Baykara Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation Eur. J. Pharm. Biopharm. 56 2003 453 459